Trial Profile
Evaluation of the efficacy and safety of a Macugen monotherapy versus Combined Therapies in the Treatment of Diabetic Retinopathy - a single centre, randomized, prospective Phase II trial.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 28 Feb 2014
Price :
$35
*
At a glance
- Drugs Pegaptanib (Primary) ; Triamcinolone
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 07 Jun 2011 New trial record